Literature DB >> 14612550

Distinct molecular conformations of the estrogen receptor alpha complex exploited by environmental estrogens.

David Bentrem1, Jennifer E Fox, Sandra Timm Pearce, Hong Liu, Sam Pappas, David Kupfer, James W Zapf, V Craig Jordan.   

Abstract

We have advanced the view that estrogens activate the estrogen receptor (ER) alpha complex differently. A group of planar (estradiol, genistein, and coumestrol) and nonplanar (methoxychlor and its mono- and didemethylated phenolic metabolites) environmental estrogens, which are all full estrogens in MCF-7 breast cancer cell proliferation assays, was shown to segregate discretely into planar and nonplanar groups. These groups were delineated using a novel assay of mutant ER cDNAs stably transfected into MDA-MB-231 cells and the activation of the transforming growth factor alpha target gene in situ that putatively describes the external shape of the ER complex. Planar compounds activate estrogen action through the two traditional activation functions (AFs), AF1 and AF2, in the ER. In contrast, nonplanar compounds can activate estrogen action through AF1 and the amino acids Asp-351 and Asp-538, which are exposed when helix 12 silences AF2. The observation that class I (planar) and class II (nonplanar) compounds have different mechanisms of estrogen action may have important implications for tissue selective modulation of the ER.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612550

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Structure-function relationships of estrogenic triphenylethylenes related to endoxifen and 4-hydroxytamoxifen.

Authors:  Philipp Y Maximov; Cynthia B Myers; Ramona F Curpan; Joan S Lewis-Wambi; V Craig Jordan
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

2.  The Conformation of the Estrogen Receptor Directs Estrogen-Induced Apoptosis in Breast Cancer: A Hypothesis.

Authors:  Philipp Maximov; Surojeet Sengupta; Joan S Lewis-Wambi; Helen R Kim; Ramona F Curpan; V Craig Jordan
Journal:  Horm Mol Biol Clin Investig       Date:  2011-03-01

Review 3.  The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.

Authors:  Ping Fan; Philipp Y Maximov; Ramona F Curpan; Balkees Abderrahman; V Craig Jordan
Journal:  Mol Cell Endocrinol       Date:  2015-06-05       Impact factor: 4.102

4.  Apigenin inhibits NNK-induced focal adhesion kinase activation in pancreatic cancer cells.

Authors:  Hung Pham; Monica Chen; Hiroki Takahashi; Jonathan King; Howard A Reber; Oscar Joe Hines; Stephen Pandol; Guido Eibl
Journal:  Pancreas       Date:  2012-11       Impact factor: 3.327

5.  Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells.

Authors:  S Sengupta; I Obiorah; P Y Maximov; R Curpan; V C Jordan
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

6.  Ligand structure-dependent activation of estrogen receptor alpha/Sp by estrogens and xenoestrogens.

Authors:  Fei Wu; Shaheen Khan; Qian Wu; Rola Barhoumi; Robert Burghardt; Stephen Safe
Journal:  J Steroid Biochem Mol Biol       Date:  2008-02-23       Impact factor: 4.292

Review 7.  Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team.

Authors:  V Craig Jordan
Journal:  Breast Cancer Res Treat       Date:  2021-08-16       Impact factor: 4.872

Review 8.  Targeting oestrogen to kill the cancer but not the patient.

Authors:  J S Lewis; D Cheng; V C Jordan
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.